FDA EUA Clearance for SARS-CoV-2 expected this quarter - We knew that from previous announcement.
First mention of "First US Customer" for SARS-CoV-2? - great news as they say it'll be first of many in the US market and most likely to move onto other multiplex kits.
STI-Genital kit is another big step (biggest global addressable market), it'll more than double our revenue once we get the approval.Combine this with last quarterly update, indicative revenue for April alone is ~1.7M. With new 3 potential customers in Europe (if all successful), the minimum contracted uptake is greater than $3.7M. Conservative estimate if 1/3 of that revenue falls into Q4, it'll be ~$1.2M. Adding revenue from regular customers for May, June on top of that. You know what I mean
I'll stop there...
I'll be topping up more as i believe we'll see long term uptrend in SP.
FDA EUA Clearance for SARS-CoV-2 expected this quarter - We knew...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.36M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 34.5¢ | $93.63K | 271.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 4501 | 1 |
View Market Depth
| Last trade - 15.03pm 25/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |